Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-05-01 Sale | 2024-05-02 9:07 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 5,000 | $20.15 | $100,750 | 318,306 (Indirect Direct) | View |
| 2024-04-01 Sale | 2024-04-03 6:55 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 5,000 | $24.38 | $121,913 | 323,306 (Indirect Direct) | View |
| 2024-03-13 Sale | 2024-03-15 4:45 pm | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 723 | $28.33 | $20,483 | 77,692 (Direct) | View |
| 2024-03-13 Sale | 2024-03-15 4:44 pm | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 724 | $28.33 | $20,511 | 49,630 (Direct) | View |
| 2024-03-13 Sale | 2024-03-15 4:43 pm | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 1,969 | $28.33 | $55,782 | 589,447 (Direct) | View |
| 2024-03-13 Sale | 2024-03-15 4:42 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 651 | $28.33 | $18,443 | 328,306 (Indirect Direct) | View |
| 2024-03-13 Sale | 2024-03-15 4:42 pm | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 619 | $28.33 | $17,536 | 182,558 (Direct) | View |
| 2024-03-04 Sale | 2024-03-06 8:14 pm | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 75,000 | $32.87 | $2,465,063 | 845,811 (Direct) | View |
| 2024-03-04 Sale | 2024-03-06 8:13 pm | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 20,646 | $35.49 | $732,727 | 167,941 (Direct) | View |
| 2023-12-27 Sale | 2023-12-29 8:30 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 5,414 | $24 | $129,936 | 288,195 (Indirect Direct) | View |
| 2023-12-14 Sale | 2023-12-18 8:49 pm | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 597 | $20.76 | $12,394 | 77,910 (Direct) | View |
| 2023-12-14 Sale | 2023-12-18 8:40 pm | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 611 | $20.76 | $12,684 | 50,354 (Direct) | View |
| 2023-12-14 Sale | 2023-12-18 8:39 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 543 | $20.76 | $11,273 | 245,131 (Indirect Direct) | View |
| 2023-12-14 Sale | 2023-12-18 8:37 pm | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 1,628 | $20.76 | $33,797 | 550,911 (Direct) | View |
| 2023-12-14 Sale | 2023-12-18 8:29 pm | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 514 | $20.76 | $10,671 | 182,672 (Direct) | View |
| 2023-12-08 Purchase | 2023-12-11 9:06 pm | Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director | 100,000 | $19.83 | $1,982,940 | 802,168 (Indirect Direct) | View |
| 2023-12-07 Sale | 2023-12-11 8:59 pm | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 26,978 | $20.02 | $539,969 | 1,031,224 (Direct) | View |
| 2023-11-30 Purchase | 2023-12-05 08:37 am | Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director | 100,000 | $16.95 | $1,694,565 | 702,168 (Indirect Direct) | View |
| 2023-11-17 Sale | 2023-11-21 5:30 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 30,000 | $14.68 | $440,259 | 213,177 (Indirect Direct) | View |
| 2023-10-02 Sale | 2023-10-04 8:41 pm | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 25,000 | $47.91 | $1,197,827 | 500,998 (Direct) | View |
| 2023-10-02 Sale | 2023-10-04 8:33 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 490 | $51.1 | $25,039 | 329,908 (Indirect Direct) | View |
| 2023-09-13 Sale | 2023-09-25 8:36 pm | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 1,682 | $50.34 | $84,672 | 460,998 (Direct) | View |
| 2023-09-13 Sale | 2023-09-25 8:31 pm | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 632 | $50.34 | $31,815 | 18,468 (Direct) | View |
| 2023-09-13 Sale | 2023-09-25 8:31 pm | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 5,617 | $48.32 | $271,416 | 71,182 (Direct) | View |
| 2023-09-13 Sale | 2023-09-25 8:30 pm | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 531 | $50.34 | $26,731 | 150,689 (Direct) | View |
| 2023-09-13 Sale | 2023-09-25 8:28 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 562 | $50.34 | $28,291 | 243,177 (Indirect Direct) | View |
| 2023-09-01 Sale | 2023-09-18 6:48 pm | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 25,000 | $49.77 | $1,244,248 | 527,680 (Direct) | View |
| 2023-08-28 Sale | 2023-08-30 7:04 pm | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 5,745 | $49.99 | $287,191 | 76,799 (Direct) | View |
| 2023-08-08 Purchase | 2023-08-10 4:46 pm | Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director | 25,000 | $42.06 | $1,051,475 | 602,168 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-29 Option Award | 2024-05-01 7:36 pm | N/A 2034-04-28 | Akero Therapeutics Inc. | AKRO | Gangloff Scott A. Chief Technology Officer | 225,000 | $0 | 225,000 (Direct) | View |
| 2024-03-04 Exercise | 2024-03-06 8:14 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 17,267 | $21.1 | 845,811 (Direct) | View |
| 2024-03-04 Exercise | 2024-03-06 8:14 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 57,733 | $16 | 845,811 (Direct) | View |
| 2024-03-04 Exercise | 2024-03-06 8:14 pm | N/A 2029-06-18 | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 75,000 | $0 | 845,811 (Direct) | View |
| 2024-03-04 Exercise | 2024-03-06 8:13 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 10,646 | $21.09 | 167,941 (Direct) | View |
| 2024-03-04 Exercise | 2024-03-06 8:13 pm | N/A 2029-01-15 | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 20,646 | $0 | 167,941 (Direct) | View |
| 2024-03-04 Exercise | 2024-03-06 8:13 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 10,000 | $6.36 | 167,941 (Direct) | View |
| 2024-03-01 Exercise | 2024-03-05 5:16 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 83,321 | $0.615 | 328,957 (Direct) | View |
| 2024-03-01 Exercise | 2024-03-05 5:16 pm | N/A 2028-10-17 | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 83,321 | $0 | 328,957 (Direct) | View |
| 2024-01-02 Exercise | 2024-01-03 5:00 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 40,000 | $0.615 | 615,449 (Direct) | View |
| 2024-01-02 Exercise | 2024-01-03 5:00 pm | N/A 2028-10-17 | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 40,000 | $0 | 615,449 (Direct) | View |
| 2023-12-27 Exercise | 2023-12-29 8:30 pm | N/A 2029-01-15 | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 5,414 | $0 | 288,195 (Direct) | View |
| 2023-12-27 Exercise | 2023-12-29 8:30 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 5,414 | $6.36 | 288,195 (Direct) | View |
| 2023-12-08 Option Award | 2023-12-12 4:43 pm | N/A 2033-12-07 | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 178,734 | $0 | 197,202 (Direct) | View |
| 2023-12-08 Option Award | 2023-12-12 4:43 pm | N/A 2033-12-07 | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 178,734 | $0 | 391,911 (Direct) | View |
| 2023-12-08 Option Award | 2023-12-12 4:38 pm | N/A 2033-12-07 | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 178,734 | $0 | 329,423 (Direct) | View |
| 2023-12-08 Option Award | 2023-12-12 4:35 pm | N/A 2033-12-07 | Akero Therapeutics Inc. | AKRO | Lamy Patrick See Remarks | 102,134 | $0 | 102,134 (Direct) | View |
| 2023-12-08 Option Award | 2023-12-12 4:26 pm | N/A 2033-12-07 | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 178,734 | $0 | 224,744 (Direct) | View |
| 2023-12-08 Option Award | 2023-12-11 8:59 pm | N/A 2033-12-07 | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 503,477 | $0 | 1,031,224 (Direct) | View |
| 2023-12-07 Exercise | 2023-12-11 8:59 pm | N/A 2029-01-15 | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 26,978 | $0 | 1,031,224 (Direct) | View |
| 2023-12-07 Exercise | 2023-12-11 8:59 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 26,978 | $6.36 | 1,031,224 (Direct) | View |
| 2023-11-09 Option Award | 2023-11-13 5:37 pm | N/A 2033-11-08 | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 83,400 | $0 | 83,400 (Direct) | View |
| 2023-10-02 Exercise | 2023-10-04 8:41 pm | N/A 2029-01-15 | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 25,000 | $0 | 500,998 (Direct) | View |
| 2023-10-02 Exercise | 2023-10-04 8:41 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 25,000 | $6.36 | 500,998 (Direct) | View |
| 2023-10-02 Exercise | 2023-10-04 8:33 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 490 | $21.1 | 329,908 (Direct) | View |
| 2023-10-02 Exercise | 2023-10-04 8:33 pm | N/A 2031-12-07 | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 490 | $0 | 329,908 (Direct) | View |
| 2023-09-21 Exercise | 2023-09-25 8:31 pm | N/A 2029-01-15 | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 5,000 | $0 | 71,182 (Direct) | View |
| 2023-09-21 Exercise | 2023-09-25 8:31 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 5,000 | $6.36 | 71,182 (Direct) | View |
| 2023-09-01 Exercise | 2023-09-18 6:48 pm | N/A 2029-01-15 | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 25,000 | $0 | 527,680 (Direct) | View |
| 2023-09-01 Exercise | 2023-09-18 6:48 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 25,000 | $6.36 | 527,680 (Direct) | View |
| 2023-08-30 Exercise | 2023-08-30 7:04 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 15,000 | $0.615 | 564,892 (Direct) | View |
| 2023-08-30 Exercise | 2023-08-30 7:04 pm | N/A 2028-09-07 | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 15,000 | $0 | 564,892 (Direct) | View |
| 2023-08-28 Exercise | 2023-08-30 7:04 pm | N/A 2029-01-15 | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 5,745 | $0 | 76,799 (Direct) | View |
| 2023-08-28 Exercise | 2023-08-30 7:04 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 5,745 | $6.36 | 76,799 (Direct) | View |